AGÕæÈ˹ٷ½

STOCK TITAN

Colgate-Palmolive Company Announces 2nd Quarter 2025 Results

Rhea-AI Impact
(No impact)
Rhea-AI Sentiment
(Neutral)
Tags

Ìý

NEW YORK--(BUSINESS WIRE)-- Colgate-Palmolive Company (NYSE:CL):

  • Net sales increased 1.0%; Organic sales* increased 1.8%, including a 0.6% negative impact from lower private label pet sales
  • GAAP EPS increased 2% to $0.91; Base Business EPS* increased 1% to $0.92
  • GAAP Gross profit margin decreased 50 basis points to 60.1%; Base Business Gross profit margin* decreased 70 basis points to 60.1%
  • Net cash provided by operations was $1,484 million for the first six months of 2025
  • The Company’s leadership in toothpaste continued with its global market share at 41.1% year to date
  • The Company’s leadership in manual toothbrushes continued with its global market share at 32.4% year to date
  • The Company updated its organic sales growth guidance for full year 2025

Second Quarter Total Company Results (GAAP)

($ in millions except per share amounts)

2025

2024

Change

Net Sales

$5,110

$5,058

+1.0%

EPS (diluted)

$0.91

$0.89

+2%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Second Quarter Total Company Results (Base Business - Non-GAAP)*

Ìý

2025

2024

Change

Organic Sales Growth

+1.8%

Base Business EPS (diluted)

$0.92

$0.91

+1%

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures� later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes� and “Table 8 - Non-GAAP Reconciliations� included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Colgate-Palmolive Company (NYSE:CL) today reported results for second quarter 2025. Noel Wallace, Chairman, President and Chief Executive Officer, commented on the Base Business second quarter results, “I am pleased that Colgate-Palmolive people achieved another quarter of net sales, organic sales and earnings per share growth in the face of continued difficult market conditions worldwide, with organic sales growth improving sequentially versus the first quarter despite an even greater negative impact from lower private label pet sales.

“We feel we are well positioned to deal with the year-to-date volatility in category growth and uncertainty in global markets. Guided by our strategic framework, including our focus on innovation and the strength of our global portfolio, our teams on the ground continue to execute with excellence and focus to achieve our 2025 financial targets.�

Separately, the Company today announced a new three-year productivity program to drive future growth and support the Company’s 2030 strategy. The program includes initiatives to better align the Company’s organizational structure to support its strategic initiatives, optimize the Company’s global supply chain to drive agility and efficiencies and simplify and streamline its organizational structure to reduce overhead costs. The productivity program is projected to result in cumulative pre-tax charges, once all initiatives are approved and implemented, totaling between $200 and $300 million over the course of the three-year program. It is expected that substantially all charges resulting from the productivity program will be incurred by December 31, 2028.

Full Year 2025 Guidance

Based on current spot rates and including the estimated impact of tariffs announced and finalized as of July 31, 2025:

  • The Company still expects net sales to be up low single digits, now including a flat to low-single-digit negative impact from foreign exchange.
  • The Company now expects organic sales growth to be at the low end of 2% to 4%, including the impact over the course of 2025 of the planned exit from private label pet sales.
  • On a GAAP basis, the Company still expects both gross profit margin and advertising investment to be roughly flat as a percentage of net sales, and earnings per share to be up low single digits.
  • On a non-GAAP (Base Business) basis, the Company still expects both gross profit margin and advertising to be roughly flat as a percentage of net sales, and earnings per share to be up low single digits.

Divisional Performance

See attached "Table 6 - Geographic Sales Analysis Percentage Changes" and "Table 5 - Segment Information" for additional information on net sales and operating profit by division.

Second Quarter Sales Growth By Division

(% change 2Q 2025 vs. 2Q 2024 except % of Total Company Sales)

Ìý

Ìý

Ìý

Ìý

% of Total
Company
Sales

Net
Sales

Organic
Sales*

As
Reported
Volume**

Organic
Volume

Pricing

FX

North America(1)

20%

-1.0%

-0.9%

-0.4%

-0.4%

-0.5%

-0.1%

Latin America

24%

-4.8%

+3.4%

+0.4%

+0.4%

+3.0%

-8.2%

Europe(1)

14%

+7.8%

+2.0%

-0.2%

-0.2%

+2.2%

+5.7%

Asia Pacific

13%

+0.8%

�%

-1.6%

-1.6%

+1.6%

+0.9%

Africa/Eurasia

6%

+8.0%

+7.7%

+4.3%

+4.3%

+3.4%

+0.2%

±á¾±±ô±ô’s

23%

+3.8%

+2.0%

+0.1%

-0.9%

+2.9%

+0.8%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Total Company

100%

+1.0%

+1.8%

�%

-0.2%

+2.0%

-1.0%

Note: Table may not sum due to rounding.

Ìý

(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

Ìý

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures� later in this release for definitions of non-GAAP financial measures and to “Table 6 - Geographic Sales Analysis Percentage Changes� included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Ìý

**The impact of the acquisition of the Prime100 pet food business on as reported volume was 1.0% and 0.2% for Hill's Pet Nutrition and Total Company, respectively.

Second Quarter Operating Profit By Division

($ in millions)

Ìý

Ìý

2Q 2025

% Change vs
2Q 2024

% to Net
Sales

Change in basis
points vs 2Q 2024
% to Net Sales

North America(1)

$194

-9%

18.9%

-170

Latin America

$367

-12%

30.4%

-250

Europe(1)

$184

9%

25.0%

+40

Asia Pacific

$187

-4%

27.2%

-150

Africa/Eurasia

$65

1%

22.0%

-140

±á¾±±ô±ô’s

$264

13%

22.9%

+180

Ìý

Ìý

Ìý

Ìý

Ìý

Total Company, As Reported

$1,080

-1%

21.1%

-50

Total Company, Base Business*

$1,089

-3%

21.3%

-80

(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

Ìý

*Indicates a non-GAAP financial measure. Please refer to “Non-GAAP Financial Measures� later in this release for definitions of non-GAAP financial measures and to “Table 8 - Non-GAAP Reconciliations� included with this release for a reconciliation of these non-GAAP financial measures to the related GAAP measures.

Prepared Materials and Webcast Information

At approximately 7:00 a.m. ET today, the Company will post its prepared materials regarding second quarter results to the Investor Center section of its website at .

At 8:30 a.m. ET today, the Company will host a conference call regarding second quarter results. To access this call as a webcast, please go to Colgate-Palmolive’s website at .

About Colgate-Palmolive

Colgate-Palmolive Company is a caring, innovative growth company that is reimagining a healthier future for all people, their pets and our planet. Focused on Oral Care, Personal Care, Home Care and Pet Nutrition, we sell our products in more than 200 countries and territories under brands such as Colgate, Palmolive, elmex, hello, meridol, Sorriso, Tom’s of Maine, EltaMD, Filorga, Irish Spring, Lady Speed Stick, PCA SKIN, Protex, Sanex, Softsoap, Speed Stick, Ajax, Axion, Fabuloso, Murphy, Soupline and Suavitel, as well as ±á¾±±ô±ô’s Science Diet and ±á¾±±ô±ô’s Prescription Diet. The Company is recognized for its leadership and innovation in promoting sustainability and community wellbeing, including its achievements in decreasing plastic waste and promoting recyclability, saving water, conserving natural resources and improving children’s oral health through the Colgate Bright Smiles, Bright Futures program, which has reached approximately 1.8 billion children and their families since 1991. For more information about Colgate-Palmolive’s global business and how the Company is building a future to smile about, visit . CL-E

Market Share Information

Management uses market share information as a key indicator to monitor business health and performance. References to market share in this press release are based on a combination of consumption and market share data provided by third-party vendors, primarily Nielsen, and internal estimates. All market share references represent the percentage of the dollar value of sales of our products, relative to all product sales in the category in the countries in which the Company competes and purchases data (excluding Venezuela from all periods).

Market share data is subject to limitations on the availability of up-to-date information. In particular, market share data is currently not generally available for certain retail channels, such as eCommerce and certain club retailers and discounters. The Company measures year-to-date market shares from January 1 of the relevant year through the most recent period for which market share data is available, which typically reflects a lag time of one or two months. The Company believes that the third-party vendors it uses to provide data are reliable, but it has not verified the accuracy or completeness of the data or any assumptions underlying the data. In addition, market share information reported by the Company may be different from market share information reported by other companies due to differences in category definitions, the use of data from different countries, internal estimates and other factors.

Cautionary Statement on Forward-Looking Statements

This press release and the related webcast may contain forward-looking statements (as that term is defined in the U.S. Private Securities Litigation Reform Act of 1995 or by the Securities and Exchange Commission (SEC) in its rules, regulations and releases) that set forth anticipated results based on management’s current plans and assumptions. Such statements may relate, for example, to sales or volume growth, net selling price increases, organic sales growth, profit or profit margin levels, earnings per share levels, financial goals, the impact of foreign exchange, the impact of tariffs, the impact of geopolitical conflicts and tensions, such as the war in Ukraine, the conflict in the Middle East, tensions between China and Taiwan and global trade relations, cost reduction plans (including the productivity program announced on August 1, 2025), tax rates, interest rates, new product introductions, digital capabilities, commercial investment levels, acquisitions, divestitures, share repurchases or legal or tax proceedings, among other matters. These statements are made on the basis of the Company’s views and assumptions as of this time and the Company undertakes no obligation to update these statements whether as a result of new information, future events or otherwise, except as required by law or by the rules and regulations of the SEC. Moreover, the Company does not, nor does any other person, assume responsibility for the accuracy and completeness of these statements. The Company cautions investors that any such forward-looking statements are not guarantees of future performance and that actual events or results may differ materially from those statements. For more information about factors that could impact the Company’s business and cause actual results to differ materially from forward-looking statements, investors should refer to the Company’s filings with the SEC (including, but not limited to, the information set forth under the captions “Risk Factors� and “Cautionary Statement on Forward-Looking Statements� in the Company’s Annual Report on Form 10-K for the year ended December 31, 2024 and subsequent filings with the SEC). Copies of these filings may be obtained upon request from the Company’s Investor Relations Department or on the Company’s website at .

Non-GAAP Financial Measures

The following provides definitions and other information regarding the non-GAAP financial measures used in this press release and the related prepared materials and webcast, which may not be the same as or comparable to similar measures presented by other companies:

  • Base Business: Base Business refers to non-GAAP measures of operating results that exclude certain items. Base Business operating results exclude, as applicable, charges resulting from the ERISA litigation matter and the 2022 Global Productivity Initiative and acquisition-related costs.
  • Organic sales growth: Net sales growth excluding the impact of foreign exchange, acquisitions and divestments.
  • Free cash flow before dividends: Net cash provided by operations less Capital expenditures.

This press release discusses Net sales growth (GAAP) and Organic sales growth (non-GAAP). Management believes the organic sales growth measure provides investors and analysts with useful supplemental information regarding the Company’s underlying sales trends by presenting sales growth excluding the external factor of foreign exchange as well as the impact from acquisitions and divestments. See “Geographic Sales Analysis Percentage Changes� for the three and six months ended June 30, 2025 versus 2024 included with this release for a comparison of Organic sales growth to Net sales growth in accordance with GAAP.

Gross profit, Gross profit margin, Selling, general and administrative expenses, Selling, general and administrative expenses as a percentage of Net sales, Other (income) expense, net, Operating profit, Operating profit margin, Non-service related postretirement costs, Effective income tax rate, Net income attributable to Colgate-Palmolive Company and Diluted earnings per common share are disclosed on both an as reported (GAAP) and Base Business (non-GAAP) basis. These non-GAAP financial measures exclude items that, either by their nature or amount, management would not expect to occur as part of the Company’s normal business on a regular basis, such as restructuring charges, charges for certain litigation and tax matters, acquisition-related costs, gains and losses from certain divestitures and certain other unusual, non-recurring items. Investors and analysts use these financial measures in assessing the Company’s business performance, and management believes that presenting these financial measures on a non-GAAP basis provides them with useful supplemental information to enhance their understanding of the Company’s underlying business performance and trends. These non-GAAP financial measures also enhance the ability to compare period-to-period financial results. See “Non-GAAP Reconciliations� for the three and six months ended June 30, 2025 and 2024 included with this release for a reconciliation of these financial measures to the related GAAP measures.

The Company uses these financial measures internally in its budgeting process, to evaluate segment and overall operating performance and as factors in determining compensation. While the Company believes that these financial measures are useful in evaluating the Company’s underlying business performance and trends, this information should be considered as supplemental in nature and is not meant to be considered in isolation or as a substitute for the related financial information prepared in accordance with GAAP.

As management uses free cash flow before dividends to evaluate the Company’s ability to satisfy current and future obligations, pay dividends, fund future business opportunities and repurchase stock, the Company believes that it provides useful information to investors. Free cash flow before dividends is not a measure of cash available for discretionary expenditures since the Company has certain non-discretionary obligations such as debt service that are not deducted from the measure. See “Condensed Consolidated Statements of Cash Flows� for the six months ended June 30, 2025 and 2024 for a comparison of free cash flow before dividends to Net cash provided by operations as reported in accordance with GAAP.

(See attached tables for second quarter results.)

Ìý

Ìý

Ìý

Ìý

Table 1

Colgate-Palmolive Company

Ìý

Condensed Consolidated Statements of Income

Ìý

For the Three Months Ended June 30, 2025 and 2024

Ìý

(Dollars in Millions Except Per Share Amounts) (Unaudited)

Ìý

Ìý

Ìý

2025

Ìý

2024

Ìý

Ìý

Ìý

Ìý

Ìý

Net sales

Ìý

$

5,110

Ìý

Ìý

$

5,058

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Cost of sales

Ìý

Ìý

2,041

Ìý

Ìý

Ìý

1,992

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Gross profit

Ìý

Ìý

3,069

Ìý

Ìý

Ìý

3,066

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Gross profit margin

Ìý

Ìý

60.1

%

Ìý

Ìý

60.6

%

Ìý

Ìý

Ìý

Ìý

Ìý

Selling, general and administrative expenses

Ìý

Ìý

1,963

Ìý

Ìý

Ìý

1,939

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Other (income) expense, net

Ìý

Ìý

26

Ìý

Ìý

Ìý

35

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Operating profit

Ìý

Ìý

1,080

Ìý

Ìý

Ìý

1,092

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Operating profit margin

Ìý

Ìý

21.1

%

Ìý

Ìý

21.6

%

Ìý

Ìý

Ìý

Ìý

Ìý

Non-service related postretirement costs

Ìý

Ìý

23

Ìý

Ìý

Ìý

22

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Interest expense

Ìý

Ìý

71

Ìý

Ìý

Ìý

78

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Interest income

Ìý

Ìý

21

Ìý

Ìý

Ìý

18

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Income before income taxes

Ìý

Ìý

1,007

Ìý

Ìý

Ìý

1,010

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Provision for income taxes

Ìý

Ìý

234

Ìý

Ìý

Ìý

243

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Effective tax rate

Ìý

Ìý

23.2

%

Ìý

Ìý

24.1

%

Ìý

Ìý

Ìý

Ìý

Ìý

Net income including noncontrolling interests

Ìý

Ìý

773

Ìý

Ìý

Ìý

767

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Less: Net income attributable to noncontrolling interests

Ìý

Ìý

30

Ìý

Ìý

Ìý

36

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Net income attributable to Colgate-Palmolive Company

Ìý

$

743

Ìý

Ìý

$

731

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Earnings per common share

Ìý

Ìý

Ìý

Ìý

Basic

Ìý

$

0.92

Ìý

Ìý

$

0.89

Ìý

Diluted

Ìý

$

0.91

Ìý

Ìý

$

0.89

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Supplemental Income Statement Information

Ìý

Ìý

Ìý

Ìý

Average common shares outstanding

Ìý

Ìý

Ìý

Ìý

Basic

Ìý

Ìý

810.2

Ìý

Ìý

Ìý

819.7

Ìý

Diluted

Ìý

Ìý

813.3

Ìý

Ìý

Ìý

823.7

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Advertising

Ìý

$

678

Ìý

Ìý

$

706

Ìý

Ìý

Ìý

Ìý

Ìý

Table 2

Colgate-Palmolive Company

Ìý

Condensed Consolidated Statements of Income

Ìý

For the Six Months Ended June 30, 2025 and 2024

Ìý

(Dollars in Millions Except Per Share Amounts) (Unaudited)

Ìý

Ìý

Ìý

2025

Ìý

2024

Ìý

Ìý

Ìý

Ìý

Ìý

Net sales

Ìý

$

10,021

Ìý

Ìý

$

10,124

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Cost of sales

Ìý

Ìý

3,965

Ìý

Ìý

Ìý

4,019

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Gross profit

Ìý

Ìý

6,056

Ìý

Ìý

Ìý

6,105

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Gross profit margin

Ìý

Ìý

60.4

%

Ìý

Ìý

60.3

%

Ìý

Ìý

Ìý

Ìý

Ìý

Selling, general and administrative expenses

Ìý

Ìý

3,861

Ìý

Ìý

Ìý

3,855

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Other (income) expense, net

Ìý

Ìý

39

Ìý

Ìý

Ìý

111

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Operating profit

Ìý

Ìý

2,156

Ìý

Ìý

Ìý

2,139

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Operating profit margin

Ìý

Ìý

21.5

%

Ìý

Ìý

21.1

%

Ìý

Ìý

Ìý

Ìý

Ìý

Non-service related postretirement costs

Ìý

Ìý

95

Ìý

Ìý

Ìý

44

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Interest expense

Ìý

Ìý

137

Ìý

Ìý

Ìý

151

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Interest income

Ìý

Ìý

35

Ìý

Ìý

Ìý

33

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Income before income taxes

Ìý

Ìý

1,959

Ìý

Ìý

Ìý

1,977

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Provision for income taxes

Ìý

Ìý

460

Ìý

Ìý

Ìý

482

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Effective tax rate

Ìý

Ìý

23.5

%

Ìý

Ìý

24.4

%

Ìý

Ìý

Ìý

Ìý

Ìý

Net income including noncontrolling interests

Ìý

Ìý

1,499

Ìý

Ìý

Ìý

1,495

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Less: Net income attributable to noncontrolling interests

Ìý

Ìý

66

Ìý

Ìý

Ìý

81

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Net income attributable to Colgate-Palmolive Company

Ìý

$

1,433

Ìý

Ìý

$

1,414

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Earnings per common share

Ìý

Ìý

Ìý

Ìý

Basic(1)

Ìý

$

1.77

Ìý

Ìý

$

1.72

Ìý

Diluted(1)

Ìý

$

1.76

Ìý

Ìý

$

1.71

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Supplemental Income Statement Information

Ìý

Ìý

Ìý

Ìý

Average common shares outstanding

Ìý

Ìý

Ìý

Ìý

Basic

Ìý

Ìý

811.2

Ìý

Ìý

Ìý

821.3

Ìý

Diluted

Ìý

Ìý

814.2

Ìý

Ìý

Ìý

824.9

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Advertising

Ìý

$

1,346

Ìý

Ìý

$

1,378

Ìý

Note:

(1) Basic and diluted earnings per share are computed independently for each quarter and any year-to-date period presented. As a result of changes in shares outstanding during the year and rounding, the sum of the quarters' earnings per share may not equal the earnings per share for any year-to-date period.

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Table 3

Colgate-Palmolive Company

Ìý

Condensed Consolidated Balance Sheets

Ìý

As of June 30, 2025, December 31, 2024 and June 30, 2024

Ìý

(Dollars in Millions) (Unaudited)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

June 30,

Ìý

December 31,

Ìý

June 30,

Ìý

Ìý

2025

Ìý

2024

Ìý

2024

Cash and cash equivalents

Ìý

$

1,215

Ìý

Ìý

$

1,096

Ìý

Ìý

$

1,110

Ìý

Receivables, net

Ìý

Ìý

1,773

Ìý

Ìý

Ìý

1,521

Ìý

Ìý

Ìý

1,825

Ìý

Inventories

Ìý

Ìý

2,120

Ìý

Ìý

Ìý

1,987

Ìý

Ìý

Ìý

1,922

Ìý

Other current assets

Ìý

Ìý

888

Ìý

Ìý

Ìý

713

Ìý

Ìý

Ìý

789

Ìý

Property, plant and equipment, net

Ìý

Ìý

4,529

Ìý

Ìý

Ìý

4,422

Ìý

Ìý

Ìý

4,392

Ìý

Goodwill

Ìý

Ìý

3,696

Ìý

Ìý

Ìý

3,272

Ìý

Ìý

Ìý

3,320

Ìý

Other intangible assets, net

Ìý

Ìý

1,904

Ìý

Ìý

Ìý

1,756

Ìý

Ìý

Ìý

1,814

Ìý

Other assets

Ìý

Ìý

1,345

Ìý

Ìý

Ìý

1,279

Ìý

Ìý

Ìý

1,308

Ìý

Total assets

Ìý

$

17,470

Ìý

Ìý

$

16,046

Ìý

Ìý

$

16,480

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Total debt

Ìý

$

8,758

Ìý

Ìý

$

7,949

Ìý

Ìý

$

8,676

Ìý

Other current liabilities

Ìý

Ìý

5,161

Ìý

Ìý

Ìý

5,099

Ìý

Ìý

Ìý

4,820

Ìý

Other non-current liabilities

Ìý

Ìý

2,499

Ìý

Ìý

Ìý

2,454

Ìý

Ìý

Ìý

2,502

Ìý

Total liabilities

Ìý

Ìý

16,418

Ìý

Ìý

Ìý

15,502

Ìý

Ìý

Ìý

15,998

Ìý

Total Colgate-Palmolive Company shareholders� equity

Ìý

Ìý

702

Ìý

Ìý

Ìý

212

Ìý

Ìý

Ìý

123

Ìý

Noncontrolling interests

Ìý

Ìý

350

Ìý

Ìý

Ìý

332

Ìý

Ìý

Ìý

359

Ìý

Total liabilities and equity

Ìý

$

17,470

Ìý

Ìý

$

16,046

Ìý

Ìý

$

16,480

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Supplemental Balance Sheet Information

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Debt less cash, cash equivalents and marketable securities(1)

Ìý

$

7,346

Ìý

Ìý

$

6,693

Ìý

Ìý

$

7,341

Ìý

Working capital % of sales

Ìý

Ìý

(2.9

)%

Ìý

Ìý

(5.2

)%

Ìý

Ìý

(2.5

)%

Note:

(1) Marketable securities of $197, $160 and $225 as of June 30, 2025, December 31, 2024 and June 30, 2024, respectively, are included in Other current assets.

Ìý

Ìý

Ìý

Ìý

Table 4

Colgate-Palmolive Company

Ìý

Condensed Consolidated Statements of Cash Flows

Ìý

For the Six Months Ended June 30, 2025 and 2024

Ìý

(Dollars in Millions) (Unaudited)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

2025

Ìý

2024

Operating Activities

Ìý

Ìý

Ìý

Ìý

Net income including noncontrolling interests

Ìý

$

1,499

Ìý

Ìý

$

1,495

Ìý

Adjustments to reconcile net income including noncontrolling interests to net cash provided by operations:

Ìý

Ìý

Depreciation and amortization

Ìý

Ìý

299

Ìý

Ìý

Ìý

307

Ìý

ERISA litigation matter

Ìý

Ìý

65

Ìý

Ìý

Ìý

�

Ìý

Restructuring and termination benefits, net of cash

Ìý

Ìý

(13

)

Ìý

Ìý

48

Ìý

Stock-based compensation expense

Ìý

Ìý

55

Ìý

Ìý

Ìý

43

Ìý

Deferred income taxes

Ìý

Ìý

(17

)

Ìý

Ìý

(92

)

Cash effects of changes in:

Ìý

Ìý

Ìý

Ìý

Receivables

Ìý

Ìý

(152

)

Ìý

Ìý

(309

)

Inventories

Ìý

Ìý

3

Ìý

Ìý

Ìý

(17

)

Accounts payable and other accruals

Ìý

Ìý

(248

)

Ìý

Ìý

194

Ìý

Other non-current assets and liabilities

Ìý

Ìý

(7

)

Ìý

Ìý

2

Ìý

Net cash provided by (used in) operations

Ìý

Ìý

1,484

Ìý

Ìý

Ìý

1,671

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Investing Activities

Ìý

Ìý

Ìý

Ìý

Capital expenditures

Ìý

Ìý

(232

)

Ìý

Ìý

(243

)

Purchases of marketable securities and investments

Ìý

Ìý

(384

)

Ìý

Ìý

(243

)

Proceeds from sale of marketable securities and investments

Ìý

Ìý

350

Ìý

Ìý

Ìý

178

Ìý

Payment for acquisition, net of cash acquired

Ìý

Ìý

(293

)

Ìý

Ìý

�

Ìý

Other investing activities

Ìý

Ìý

(1

)

Ìý

Ìý

4

Ìý

Net cash provided by (used in) investing activities

Ìý

Ìý

(560

)

Ìý

Ìý

(304

)

Ìý

Ìý

Ìý

Ìý

Ìý

Financing Activities

Ìý

Ìý

Ìý

Ìý

Short-term borrowing (repayment) less than 90 days, net

Ìý

Ìý

(30

)

Ìý

Ìý

736

Ìý

Principal payments on debt

Ìý

Ìý

(139

)

Ìý

Ìý

(500

)

Proceeds from issuance of debt

Ìý

Ìý

497

Ìý

Ìý

Ìý

2

Ìý

Dividends paid

Ìý

Ìý

(880

)

Ìý

Ìý

(867

)

Purchases of treasury shares

Ìý

Ìý

(516

)

Ìý

Ìý

(989

)

Proceeds from exercise of stock options

Ìý

Ìý

65

Ìý

Ìý

Ìý

455

Ìý

Other financing activities

Ìý

Ìý

136

Ìý

Ìý

Ìý

(43

)

Net cash provided by (used in) financing activities

Ìý

Ìý

(867

)

Ìý

Ìý

(1,206

)

Ìý

Ìý

Ìý

Ìý

Ìý

Effect of exchange rate changes on Cash and cash equivalents

Ìý

Ìý

62

Ìý

Ìý

Ìý

(17

)

Net increase (decrease) in Cash and cash equivalents

Ìý

Ìý

119

Ìý

Ìý

Ìý

144

Ìý

Cash and cash equivalents at beginning of the period

Ìý

Ìý

1,096

Ìý

Ìý

Ìý

966

Ìý

Cash and cash equivalents at end of the period

Ìý

$

1,215

Ìý

Ìý

$

1,110

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Supplemental Cash Flow Information

Ìý

Ìý

Ìý

Ìý

Free cash flow before dividends (Net cash provided by operations less Capital expenditures)

Ìý

Ìý

Ìý

Ìý

Net cash provided by operations

Ìý

$

1,484

Ìý

Ìý

$

1,671

Ìý

Less: Capital expenditures

Ìý

Ìý

(232

)

Ìý

Ìý

(243

)

Free cash flow before dividends

Ìý

$

1,252

Ìý

Ìý

$

1,428

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Income taxes paid

Ìý

$

530

Ìý

Ìý

$

505

Ìý

Interest paid

Ìý

$

137

Ìý

Ìý

$

161

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Table 5

Colgate-Palmolive Company

Ìý

Ìý

Ìý

Ìý

Ìý

Segment Information

Ìý

Ìý

Ìý

Ìý

Ìý

For the Three and Six Months Ended June 30, 2025 and 2024

Ìý

Ìý

Ìý

Ìý

Ìý

(Dollars in Millions) (Unaudited)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Three Months Ended June 30,

Ìý

Six Months Ended June 30,

Ìý

Ìý

2025

Ìý

2024

Ìý

2025

Ìý

2024

Net Sales

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Oral, Personal and Home Care

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

North America(1)

Ìý

$

1,027

Ìý

Ìý

$

1,037

Ìý

Ìý

$

2,025

Ìý

Ìý

$

2,073

Ìý

Latin America

Ìý

Ìý

1,207

Ìý

Ìý

Ìý

1,267

Ìý

Ìý

Ìý

2,350

Ìý

Ìý

Ìý

2,520

Ìý

Europe(1)

Ìý

Ìý

738

Ìý

Ìý

Ìý

685

Ìý

Ìý

Ìý

1,427

Ìý

Ìý

Ìý

1,358

Ìý

Asia Pacific

Ìý

Ìý

687

Ìý

Ìý

Ìý

682

Ìý

Ìý

Ìý

1,378

Ìý

Ìý

Ìý

1,408

Ìý

Africa/Eurasia

Ìý

Ìý

295

Ìý

Ìý

Ìý

273

Ìý

Ìý

Ìý

566

Ìý

Ìý

Ìý

549

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Total Oral, Personal and Home Care

Ìý

Ìý

3,954

Ìý

Ìý

Ìý

3,944

Ìý

Ìý

Ìý

7,746

Ìý

Ìý

Ìý

7,908

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Pet Nutrition

Ìý

Ìý

1,157

Ìý

Ìý

Ìý

1,114

Ìý

Ìý

Ìý

2,275

Ìý

Ìý

Ìý

2,216

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Total Net Sales

Ìý

$

5,110

Ìý

Ìý

$

5,058

Ìý

Ìý

$

10,021

Ìý

Ìý

$

10,124

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Three Months Ended June 30,

Ìý

Six Months Ended June 30,

Ìý

Ìý

2025

Ìý

2024

Ìý

2025

Ìý

2024

Operating Profit

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Oral, Personal and Home Care

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

North America(1)

Ìý

$

194

Ìý

Ìý

$

213

Ìý

Ìý

$

390

Ìý

Ìý

$

427

Ìý

Latin America

Ìý

Ìý

367

Ìý

Ìý

Ìý

417

Ìý

Ìý

Ìý

715

Ìý

Ìý

Ìý

822

Ìý

Europe(1)

Ìý

Ìý

184

Ìý

Ìý

Ìý

169

Ìý

Ìý

Ìý

356

Ìý

Ìý

Ìý

321

Ìý

Asia Pacific

Ìý

Ìý

187

Ìý

Ìý

Ìý

195

Ìý

Ìý

Ìý

385

Ìý

Ìý

Ìý

402

Ìý

Africa/Eurasia

Ìý

Ìý

65

Ìý

Ìý

Ìý

64

Ìý

Ìý

Ìý

122

Ìý

Ìý

Ìý

130

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Total Oral, Personal and Home Care

Ìý

Ìý

997

Ìý

Ìý

Ìý

1,058

Ìý

Ìý

Ìý

1,968

Ìý

Ìý

Ìý

2,102

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Pet Nutrition

Ìý

Ìý

264

Ìý

Ìý

Ìý

235

Ìý

Ìý

Ìý

523

Ìý

Ìý

Ìý

433

Ìý

Corporate(2)

Ìý

Ìý

(181

)

Ìý

Ìý

(201

)

Ìý

Ìý

(334

)

Ìý

Ìý

(397

)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Total Operating Profit

Ìý

$

1,080

Ìý

Ìý

$

1,092

Ìý

Ìý

$

2,156

Ìý

Ìý

$

2,139

Ìý

Note: Table may not sum due to rounding.

Ìý

(1) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

Ìý

(2) Corporate operations include costs related to stock options and restricted stock units, research and development costs, Corporate overhead costs, restructuring and related implementation charges and gains and losses on sales of non-core product lines and assets.

Ìý

Corporate Operating profit (loss) for the three months ended June 30, 2025 included acquisition-related costs of $9.

Ìý

Corporate Operating profit (loss) for the six months ended June 30, 2025 included charges resulting from the ERISA litigation matter of $15 and acquisition-related costs of $9.

Ìý

Corporate Operating profit (loss) for the three months ended June 30, 2024 included charges resulting from the 2022 Global Productivity Initiative of $27.

Ìý

Corporate Operating profit (loss) for the six months ended June 30, 2024 included charges resulting from the 2022 Global Productivity Initiative of $63.

Table 6

Colgate-Palmolive Company

Ìý

Geographic Sales Analysis Percentage Changes

Ìý

For the Three Months Ended June 30, 2025 vs. 2024

Ìý

(Unaudited)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

COMPONENTS OF SALES CHANGE

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Pricing

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Coupons

Ìý

Ìý

Ìý

Ìý

Sales

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Consumer &

Ìý

Ìý

Ìý

Ìý

Change

Ìý

Organic

Ìý

As Reported

Ìý

Organic

Ìý

Trade

Ìý

Foreign

Region

Ìý

As Reported

Ìý

Sales Change

Ìý

Volume(1)

Ìý

Volume

Ìý

Incentives

Ìý

Exchange

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Total Company

Ìý

1.0

%

Ìý

1.8

%

Ìý

�

%

Ìý

(0.2

)%

Ìý

2.0

%

Ìý

(1.0

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

North America(2)

Ìý

(1.0

)%

Ìý

(0.9

)%

Ìý

(0.4

)%

Ìý

(0.4

)%

Ìý

(0.5

)%

Ìý

(0.1

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Latin America

Ìý

(4.8

)%

Ìý

3.4

%

Ìý

0.4

%

Ìý

0.4

%

Ìý

3.0

%

Ìý

(8.2

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Europe(2)

Ìý

7.8

%

Ìý

2.0

%

Ìý

(0.2

)%

Ìý

(0.2

)%

Ìý

2.2

%

Ìý

5.7

%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Asia Pacific

Ìý

0.8

%

Ìý

�

%

Ìý

(1.6

)%

Ìý

(1.6

)%

Ìý

1.6

%

Ìý

0.9

%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Africa/Eurasia

Ìý

8.0

%

Ìý

7.7

%

Ìý

4.3

%

Ìý

4.3

%

Ìý

3.4

%

Ìý

0.2

%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Total CP Products

Ìý

0.2

%

Ìý

1.7

%

Ìý

�

%

Ìý

�

%

Ìý

1.7

%

Ìý

(1.5

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

±á¾±±ô±ô’s

Ìý

3.8

%

Ìý

2.0

%

Ìý

0.1

%

Ìý

(0.9

)%

Ìý

2.9

%

Ìý

0.8

%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Emerging Markets(3)

Ìý

(1.1

)%

Ìý

2.8

%

Ìý

0.2

%

Ìý

0.2

%

Ìý

2.6

%

Ìý

(3.9

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Developed Markets

Ìý

2.8

%

Ìý

0.9

%

Ìý

(0.1

)%

Ìý

(0.5

)%

Ìý

1.4

%

Ìý

1.4

%

Note: Table may not sum due to rounding.

Ìý

(1) The impact of the acquisition of the Prime100 pet food business on as reported volume was 0.2%, 1.0% and 0.4% for Total Company, Hill's Pet Nutrition and Developed Markets, respectively.

Ìý

(2) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

Ìý

(3) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

Table 7

Colgate-Palmolive Company

Ìý

Geographic Sales Analysis Percentage Changes

Ìý

For the Six Months Ended June 30, 2025 vs. 2024

Ìý

(Unaudited)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

COMPONENTS OF SALES CHANGE

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Pricing

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Coupons

Ìý

Ìý

Ìý

Ìý

Sales

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Consumer &

Ìý

Ìý

Ìý

Ìý

Change

Ìý

Organic

Ìý

As Reported

Ìý

Organic

Ìý

Trade

Ìý

Foreign

Region

Ìý

As Reported

Ìý

Sales Change

Ìý

Volume(1)

Ìý

Volume

Ìý

Incentives

Ìý

Exchange

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Total Company

Ìý

(1.0

)%

Ìý

1.6

%

Ìý

�

%

Ìý

(0.1

)%

Ìý

1.7

%

Ìý

(2.7

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

North America(2)

Ìý

(2.3

)%

Ìý

(2.0

)%

Ìý

(1.4

)%

Ìý

(1.4

)%

Ìý

(0.6

)%

Ìý

(0.3

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Latin America

Ìý

(6.8

)%

Ìý

3.7

%

Ìý

1.6

%

Ìý

1.6

%

Ìý

2.1

%

Ìý

(10.4

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Europe(2)

Ìý

5.2

%

Ìý

3.7

%

Ìý

1.4

%

Ìý

1.4

%

Ìý

2.3

%

Ìý

1.5

%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Asia Pacific

Ìý

(2.2

)%

Ìý

(1.6

)%

Ìý

(2.6

)%

Ìý

(2.6

)%

Ìý

1.0

%

Ìý

(0.6

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Africa/Eurasia

Ìý

3.2

%

Ìý

4.8

%

Ìý

1.0

%

Ìý

1.0

%

Ìý

3.7

%

Ìý

(1.6

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Total CP Products

Ìý

(2.0

)%

Ìý

1.3

%

Ìý

�

%

Ìý

�

%

Ìý

1.3

%

Ìý

(3.4

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

±á¾±±ô±ô’s

Ìý

2.6

%

Ìý

2.5

%

Ìý

(0.1

)%

Ìý

(0.6

)%

Ìý

3.0

%

Ìý

(0.3

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Emerging Markets(3)

Ìý

(3.7

)%

Ìý

2.2

%

Ìý

0.2

%

Ìý

0.2

%

Ìý

2.0

%

Ìý

(5.9

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Developed Markets

Ìý

1.2

%

Ìý

1.0

%

Ìý

(0.2

)%

Ìý

(0.4

)%

Ìý

1.5

%

Ìý

�

%

Note: Table may not sum due to rounding.

Ìý

(1) The impact of the acquisition of the Prime100 pet food business on as reported volume was 0.1%, 0.5% and 0.2% for Total Company, Hill's Pet Nutrition and Developed Markets, respectively.

Ìý

(2) The Company has recast its historical geographic segment information to conform to the reporting structure effective as of July 1, 2024.

Ìý

(3) Emerging Markets include Latin America, Asia (excluding Japan), Africa/Eurasia and Central Europe.

Table 8

Colgate-Palmolive Company

Ìý

Non-GAAP Reconciliations

Ìý

For the Three Months Ended June 30, 2025 and 2024

Ìý

(Dollars in Millions Except Per Share Amounts) (Unaudited)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Gross Profit

Ìý

2025

Ìý

2024

Ìý

Ìý

Gross profit, GAAP

$

3,069

Ìý

Ìý

$

3,066

Ìý

Ìý

Ìý

2022 Global Productivity Initiative

Ìý

�

Ìý

Ìý

Ìý

9

Ìý

Ìý

Ìý

Gross profit, non-GAAP

$

3,069

Ìý

Ìý

$

3,075

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Basis Point

Gross Profit Margin

2025

Ìý

2024

Ìý

Change

Gross profit margin, GAAP

Ìý

60.1

%

Ìý

Ìý

60.6

%

Ìý

(50

)

2022 Global Productivity Initiative

Ìý

�

%

Ìý

Ìý

0.2

%

Ìý

Ìý

Gross profit margin, non-GAAP

Ìý

60.1

%

Ìý

Ìý

60.8

%

Ìý

(70

)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Selling, General and Administrative Expenses

2025

Ìý

2024

Ìý

Ìý

Selling, general and administrative expenses, GAAP

$

1,963

Ìý

Ìý

$

1,939

Ìý

Ìý

Ìý

2022 Global Productivity Initiative

Ìý

Ìý

�

Ìý

Ìý

Ìý

(2

)

Ìý

Ìý

Selling, general and administrative expenses, non-GAAP

$

1,963

Ìý

Ìý

$

1,937

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Other (Income) Expense, Net

2025

Ìý

2024

Ìý

Ìý

Other (income) expense, net, GAAP

$

26

Ìý

Ìý

$

35

Ìý

Ìý

Ìý

Acquisition-related costs

Ìý

Ìý

(9

)

Ìý

Ìý

�

Ìý

Ìý

Ìý

2022 Global Productivity Initiative

Ìý

Ìý

�

Ìý

Ìý

Ìý

(16

)

Ìý

Ìý

Other (income) expense, net, non-GAAP

$

17

Ìý

Ìý

$

20

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Operating Profit

Ìý

2025

Ìý

2024

Ìý

% Change

Operating profit, GAAP

$

1,080

Ìý

Ìý

$

1,092

Ìý

Ìý

(1

)%

Acquisition-related costs

Ìý

Ìý

9

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

2022 Global Productivity Initiative

Ìý

Ìý

�

Ìý

Ìý

Ìý

27

Ìý

Ìý

Ìý

Operating profit, non-GAAP

$

1,089

Ìý

Ìý

$

1,118

Ìý

Ìý

(3

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Basis Point

Operating Profit Margin

2025

Ìý

2024

Ìý

Change

Operating profit margin, GAAP

Ìý

21.1

%

Ìý

Ìý

21.6

%

Ìý

(50

)

Acquisition-related costs

Ìý

Ìý

0.2

%

Ìý

Ìý

�

%

Ìý

Ìý

2022 Global Productivity Initiative

Ìý

Ìý

�

%

Ìý

Ìý

0.5

%

Ìý

Ìý

Operating profit margin, non-GAAP

Ìý

21.3

%

Ìý

Ìý

22.1

%

Ìý

(80

)

Note: Tables may not sum due to rounding. The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP� and “non-GAAP� as a result of rounding.

Table 8

Continued

Colgate-Palmolive Company

Ìý

Non-GAAP Reconciliations

Ìý

For the Three Months Ended June 30, 2025 and 2024

Ìý

(Dollars in Millions Except Per Share Amounts) (Unaudited)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

2025

Ìý

Income
Before
Income
Taxes

Ìý

Provision
For Income
Taxes(1)

Ìý

Net Income
Including
Noncontrolling
Interests

Ìý

Less: Income
Attributable to
Noncontrolling
Interests

Ìý

Net Income
Attributable
To
Colgate-
Palmolive
Company

Ìý

Effective
Income
Tax Rate(2)

Ìý

Diluted
Earnings
Per Share

As Reported GAAP

$

1,007

Ìý

$

234

Ìý

$

773

Ìý

$

30

Ìý

$

743

Ìý

23.2

%

Ìý

$

0.91

Acquisition-related costs

Ìý

9

Ìý

Ìý

2

Ìý

Ìý

7

Ìý

Ìý

�

Ìý

Ìý

7

Ìý

�

%

Ìý

Ìý

0.01

Non-GAAP

$

1,016

Ìý

$

236

Ìý

$

780

Ìý

$

30

Ìý

$

750

Ìý

23.2

%

Ìý

$

0.92

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

2024

Ìý

Income
Before
Income
Taxes

Ìý

Provision
For Income
Taxes(1)

Ìý

Net Income
Including
Noncontrolling
Interests

Ìý

Less: Income
Attributable to
Noncontrolling
Interests

Ìý

Net Income
Attributable
To
Colgate-
Palmolive

Company

Ìý

Effective
Income
Tax Rate(2)

Ìý

Diluted
Earnings
Per Share

As Reported GAAP

$

1,010

Ìý

$

243

Ìý

$

767

Ìý

$

36

Ìý

$

731

Ìý

24.1

%

Ìý

$

0.89

2022 Global Productivity Initiative

Ìý

27

Ìý

Ìý

4

Ìý

Ìý

23

Ìý

Ìý

�

Ìý

Ìý

23

Ìý

(0.3

)%

Ìý

Ìý

0.02

Non-GAAP

$

1,036

Ìý

$

247

Ìý

$

789

Ìý

$

36

Ìý

$

753

Ìý

23.8

%

Ìý

$

0.91

Note: Tables may not sum due to rounding. The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP� and “non-GAAP� as a result of rounding.

Ìý

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

Ìý

(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustment on Income before income taxes and Provision for income taxes.

Table 9

Colgate-Palmolive Company

Ìý

Non-GAAP Reconciliations

Ìý

For the Six Months Ended June 30, 2025 and 2024

Ìý

(Dollars in Millions Except Per Share Amounts) (Unaudited)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Gross Profit

Ìý

2025

Ìý

2024

Ìý

Ìý

Gross profit, GAAP

Ìý$

6,056

Ìý

Ìý

$

6,105

Ìý

Ìý

Ìý

2022 Global Productivity Initiative

Ìý

�

Ìý

Ìý

Ìý

9

Ìý

Ìý

Ìý

Gross profit, non-GAAP

$

6,056

Ìý

Ìý

$

6,114

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Gross Profit Margin

2025

Ìý

2024

Ìý

Change

Gross profit margin, GAAP

Ìý

60.4

%

Ìý

Ìý

60.3

%

Ìý

10

Ìý

2022 Global Productivity Initiative

Ìý

�

%

Ìý

Ìý

0.1

%

Ìý

Ìý

Gross profit margin, non-GAAP

Ìý

60.4

%

Ìý

Ìý

60.4

%

Ìý

�

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Selling, General and Administrative Expenses

2025

Ìý

2024

Ìý

Ìý

Selling, general and administrative expenses, GAAP

$

3,861

Ìý

Ìý

$

3,855

Ìý

Ìý

Ìý

ERISA litigation matter

Ìý

Ìý

(15

)

Ìý

Ìý

�

Ìý

Ìý

Ìý

2022 Global Productivity Initiative

Ìý

�

Ìý

Ìý

Ìý

(3

)

Ìý

Ìý

Selling, general and administrative expenses, non-GAAP

$

3,845

Ìý

Ìý

$

3,852

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Basis Point

Selling, General and Administrative Expenses as a Percentage of Net Sales

2025

Ìý

2024

Ìý

Change

Selling, general and administrative expenses as a percentage of Net sales, GAAP

Ìý

38.5

%

Ìý

Ìý

38.1

%

Ìý

40

Ìý

ERISA litigation matter

Ìý

Ìý

(0.1

)%

Ìý

Ìý

�

%

Ìý

Ìý

2022 Global Productivity Initiative

Ìý

�

%

Ìý

Ìý

(0.1

)%

Ìý

Ìý

Selling, general and administrative expenses as a percentage of Net sales, non-GAAP

Ìý

38.4

%

Ìý

Ìý

38.0

%

Ìý

40

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Other (Income) Expense, Net

2025

Ìý

2024

Ìý

Ìý

Other (income) expense, net, GAAP

$

39

Ìý

Ìý

$

111

Ìý

Ìý

Ìý

Acquisition-related costs

Ìý

Ìý

(9

)

Ìý

Ìý

�

Ìý

Ìý

Ìý

2022 Global Productivity Initiative

Ìý

�

Ìý

Ìý

Ìý

(51

)

Ìý

Ìý

Other (income) expense, net, non-GAAP

$

30

Ìý

Ìý

$

60

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Operating Profit

Ìý

2025

Ìý

2024

Ìý

% Change

Operating profit, GAAP

$

2,156

Ìý

Ìý

$

2,139

Ìý

Ìý

1

%

ERISA litigation matter

Ìý

Ìý

15

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

Acquisition-related costs

Ìý

Ìý

9

Ìý

Ìý

Ìý

�

Ìý

Ìý

Ìý

2022 Global Productivity Initiative

Ìý

�

Ìý

Ìý

Ìý

63

Ìý

Ìý

Ìý

Operating profit, non-GAAP

$

2,181

Ìý

Ìý

$

2,202

Ìý

Ìý

(1

)%

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Basis Point

Operating Profit Margin

2025

Ìý

2024

Ìý

Change

Operating profit margin, GAAP

Ìý

21.5

%

Ìý

Ìý

21.1

%

Ìý

40

Ìý

ERISA litigation matter

Ìý

0.2

%

Ìý

Ìý

�

%

Ìý

Ìý

Acquisition-related costs

Ìý

Ìý

0.1

%

Ìý

Ìý

�

%

Ìý

Ìý

2022 Global Productivity Initiative

Ìý

�

%

Ìý

Ìý

0.7

%

Ìý

Ìý

Operating profit margin, non-GAAP

Ìý

21.8

%

Ìý

Ìý

21.8

%

Ìý

�

Ìý

Ìý

Non-Service Related Postretirement Costs

2025

Ìý

2024

Ìý

Ìý

Non-service related postretirement costs, GAAP

$

95

Ìý

Ìý

$

44

Ìý

Ìý

Ìý

ERISA litigation matter

Ìý

Ìý

(50

)

Ìý

Ìý

�

Ìý

Ìý

Ìý

Non-service related postretirement costs, non-GAAP

$

45

Ìý

Ìý

$

44

Ìý

Ìý

Ìý

Note: Tables may not sum due to rounding. The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP� and “non-GAAP� as a result of rounding.

Table 9

Continued

Colgate-Palmolive Company

Ìý

Non-GAAP Reconciliations

Ìý

For the Six Months Ended June 30, 2025 and 2024

Ìý

(Dollars in Millions Except Per Share Amounts) (Unaudited)

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

2025

Ìý

Income
Before
Income Taxes

Ìý

Provision
For
Income
Taxes(1)

Ìý

Net Income
Including
Noncontrolling
Interests

Ìý

Less: Income
Attributable to
Noncontrolling
Interests

Ìý

Net Income
Attributable
To
Colgate-
Palmolive
Company

Ìý

Effective
Income
Tax Rate(2)

Ìý

Diluted
Earnings
Per Share

As Reported GAAP

$

1,959

Ìý

$

460

Ìý

$

1,499

Ìý

$

66

Ìý

$

1,433

Ìý

23.5

%

Ìý

$

1.76

ERISA litigation matter

Ìý

65

Ìý

Ìý

12

Ìý

Ìý

53

Ìý

Ìý

�

Ìý

Ìý

53

Ìý

(0.1

)%

Ìý

Ìý

0.06

Acquisition-related costs

Ìý

9

Ìý

Ìý

2

Ìý

Ìý

7

Ìý

Ìý

�

Ìý

Ìý

7

Ìý

�

%

Ìý

Ìý

0.01

Non-GAAP

$

2,034

Ìý

$

475

Ìý

$

1,559

Ìý

$

66

Ìý

$

1,493

Ìý

23.4

%

Ìý

$

1.83

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

Ìý

2024

Ìý

Income
Before
Income Taxes

Ìý

Provision
For
Income
Taxes(1)

Ìý

Net Income
Including
Noncontrolling
Interests

Ìý

Less: Income
Attributable to
Noncontrolling
Interests

Ìý

Net Income
Attributable
To
Colgate-
Palmolive
Company

Ìý

Effective
Income
Tax Rate(2)

Ìý

Diluted
Earnings
Per Share

As Reported GAAP

$

1,977

Ìý

$

482

Ìý

$

1,495

Ìý

$

81

Ìý

$

1,414

Ìý

24.4

%

Ìý

$

1.71

2022 Global Productivity Initiative

Ìý

63

Ìý

Ìý

10

Ìý

Ìý

53

Ìý

Ìý

�

Ìý

Ìý

53

Ìý

(0.3

)%

Ìý

Ìý

0.07

Non-GAAP

$

2,040

Ìý

$

492

Ìý

$

1,548

Ìý

$

81

Ìý

$

1,467

Ìý

24.1

%

Ìý

$

1.78

Note: Tables may not sum due to rounding. The impact of non-GAAP adjustments may not necessarily equal the difference between “GAAP� and “non-GAAP� as a result of rounding.

Ìý

(1) The income tax effect on non-GAAP items is calculated based upon the tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

Ìý

(2) The impact of non-GAAP items on the Company’s effective tax rate represents the difference in the effective tax rate calculated with and without the non-GAAP adjustments on Income before income taxes and Provision for income taxes.

Ìý

Investor Relations: [email protected]

Communications: [email protected]

Source: Colgate-Palmolive Company

Colgate Palmolive Co

NYSE:CL

CL Rankings

CL Latest News

CL Latest SEC Filings

CL Stock Data

68.76B
806.82M
0.16%
86.13%
1.68%
Household & Personal Products
Perfumes, Cosmetics & Other Toilet Preparations
United States
NEW YORK